Immatics at the TMB & Neoantigen Congress (Oct 10-11) in London, UK

| News, USA

Exploring advancements in novel targets, predictive biomarkers and personalized medicine

Meet Immatics at the TMB & Neoantigen Congress and get the latest insights on tailor-made immunotherapies:

Thursday, Oct 10 (Day 1)

Morning Refreshments/ Poster Presentations

Tailor-made immunotherapies: Integrating non-mutated and neoantigens into highly personalized immunotherapy approaches

Speaker: Sarah Missel, Director Translational Development, R&D Strategy and Communications

More informations on the TMB & Neoantigen Congress can be found here.

Press Contact

Anja Heuer

Corporate Communications,
Immatics Biotechnologies GmbH

+49 89 540 415 606

Go back

We use cookies to ensure that we give you the best experience on our website.